Covid Drug
-
{
- All
- News
- Videos
-
Remove Offending Content: High Court To Ramdev On Doctors' Plea Over Coronil
The Delhi High Court directed yoga guru Ramdev today to take down certain "offending" social media posts in relation to the use of "Coronil" for COVID-19.
-
Delhi High Court Reserves Order On Doctors' Plea Against Patanjali's COVID Drug Claims
The Delhi High Court on Tuesday reserved its order on a plea by several doctors' associations against yoga exponent Ramdev over his alleged "unsubstantiated" claim about 'Coronil' being a "cure" for COVID-19 and not just an immunity booster.
-
India-Made Drug Shown To Treat Heart Damage Caused By Covid Protein: Study
A drug developed by the Defence Research and Development Organisation (DRDO) may reverse the heart damage caused by a protein in the SARS-CoV-2 virus, a study conducted in fruit flies and mice has found.
-
As Omicron Spreads Across US, New Covid Drugs In Short Supply
New treatments for early Covid-19 are now beginning to arrive at pharmacies in New York and elsewhere but remain in short supply, according to a representative of the Infectious Diseases Society of America.
-
2 Covid Pills - But Who Should Get Them? The New Dilemma
The US has cleared its first two Covid-19 treatment pills, and now comes another hurdle -- deciding who should get which one.
-
Game-Changing Made-In-India Anti-Covid Pills Could Be Cleared For Use In Days
Emergency Use Authorisation for the Merck drug Molnupiravir -- an oral antiviral medicine for the treatment of mild-to-moderate COVID-19 -- is likely "within days", Dr Ram Vishwakarma, Chairman of the Covid Strategy Group, CSIR, told NDTV today.
-
Gates Foundation Commits $120 Million To Support Access To New Covid Pill
The Bill and Melinda Gates Foundation on Wednesday announced an investment of up to $120 million in an effort to speed up low-income countries' access to a new anti-Covid drug.
-
WHO-Led Trial To Study 3 Anti-Inflammatory Drugs For Covid Patients
The World Health Organization (WHO) said on Wednesday a clinical trial in 52 countries would study three anti-inflammatory drugs as potential treatments for COVID-19 patients.
-
Mankind Pharma Gets DRDO Nod To Manufacture, Sell Covid Drug 2-DG
Drug firm Mankind Pharma today said it has received licence from the Defence Research and Development Organisation (DRDO) to manufacture and market oral 2-deoxy-D-glucose (2-DG), used for the treatment of COVID-19.
-
Covid Drug Distribution: Sonu Sood Says Acted As Conduit To Help Needy
Actor Sonu Sood today denied any wrongdoing in the distribution of anti-COVID-19 drugs by him and told the Bombay High Court that he was only helping out those who genuinely needed the medicines amid shortages.
-
Hyderabad Pharma Firm Signs Agreement To Make Covid Drug 2-DG
Hyderabad-based Lee Pharma has entered into an agreement with the Indian Institute of Chemical Technology (IICT), a constituent laboratory of CSIR, to manufacture and commercialise 2-DG used to treat Covid patients, a statement said.
-
DRDO Invites Applications From Indian Pharma Firms For Bulk Production Of Covid Drug 2-DG
The Defence Research and Development Organisation or DRDO, which developed 2-Deoxy-D-Glucose (2-DG), a drug used for treatment of COVID-19 patients, has called for Expression of Interest to transfer the technology to Indian pharmaceutical firms.
-
Mukesh Ambani's Reliance Explores Tapeworm Drug for COVID-19
Reliance Industries Ltd. is working on a new COVID-19 drug and cheaper testing kits as the conglomerate owned by Asia's richest man Mukesh Ambani looks to curb the pathogen which has ravaged India in the past year.
-
Rs 990 Per Sachet For Defence Research Body's Covid Drug '2-DG': Report
The price of a drug for COVID-19 patients developed by India's top defence research body has been fixed at Rs 990 per sachet, news agency ANI reported today quoting unnamed officials.
-
Probe Gautam Gambhir, Others Buying Covid Supplies In Bulk: High Court
The Delhi High court on Monday directed the drug controller to inquire into the issue of politicians buying COVID-19 drugs in bulk amid shortages
-
Remove Offending Content: High Court To Ramdev On Doctors' Plea Over Coronil
The Delhi High Court directed yoga guru Ramdev today to take down certain "offending" social media posts in relation to the use of "Coronil" for COVID-19.
-
Delhi High Court Reserves Order On Doctors' Plea Against Patanjali's COVID Drug Claims
The Delhi High Court on Tuesday reserved its order on a plea by several doctors' associations against yoga exponent Ramdev over his alleged "unsubstantiated" claim about 'Coronil' being a "cure" for COVID-19 and not just an immunity booster.
-
India-Made Drug Shown To Treat Heart Damage Caused By Covid Protein: Study
A drug developed by the Defence Research and Development Organisation (DRDO) may reverse the heart damage caused by a protein in the SARS-CoV-2 virus, a study conducted in fruit flies and mice has found.
-
As Omicron Spreads Across US, New Covid Drugs In Short Supply
New treatments for early Covid-19 are now beginning to arrive at pharmacies in New York and elsewhere but remain in short supply, according to a representative of the Infectious Diseases Society of America.
-
2 Covid Pills - But Who Should Get Them? The New Dilemma
The US has cleared its first two Covid-19 treatment pills, and now comes another hurdle -- deciding who should get which one.
-
Game-Changing Made-In-India Anti-Covid Pills Could Be Cleared For Use In Days
Emergency Use Authorisation for the Merck drug Molnupiravir -- an oral antiviral medicine for the treatment of mild-to-moderate COVID-19 -- is likely "within days", Dr Ram Vishwakarma, Chairman of the Covid Strategy Group, CSIR, told NDTV today.
-
Gates Foundation Commits $120 Million To Support Access To New Covid Pill
The Bill and Melinda Gates Foundation on Wednesday announced an investment of up to $120 million in an effort to speed up low-income countries' access to a new anti-Covid drug.
-
WHO-Led Trial To Study 3 Anti-Inflammatory Drugs For Covid Patients
The World Health Organization (WHO) said on Wednesday a clinical trial in 52 countries would study three anti-inflammatory drugs as potential treatments for COVID-19 patients.
-
Mankind Pharma Gets DRDO Nod To Manufacture, Sell Covid Drug 2-DG
Drug firm Mankind Pharma today said it has received licence from the Defence Research and Development Organisation (DRDO) to manufacture and market oral 2-deoxy-D-glucose (2-DG), used for the treatment of COVID-19.
-
Covid Drug Distribution: Sonu Sood Says Acted As Conduit To Help Needy
Actor Sonu Sood today denied any wrongdoing in the distribution of anti-COVID-19 drugs by him and told the Bombay High Court that he was only helping out those who genuinely needed the medicines amid shortages.
-
Hyderabad Pharma Firm Signs Agreement To Make Covid Drug 2-DG
Hyderabad-based Lee Pharma has entered into an agreement with the Indian Institute of Chemical Technology (IICT), a constituent laboratory of CSIR, to manufacture and commercialise 2-DG used to treat Covid patients, a statement said.
-
DRDO Invites Applications From Indian Pharma Firms For Bulk Production Of Covid Drug 2-DG
The Defence Research and Development Organisation or DRDO, which developed 2-Deoxy-D-Glucose (2-DG), a drug used for treatment of COVID-19 patients, has called for Expression of Interest to transfer the technology to Indian pharmaceutical firms.
-
Mukesh Ambani's Reliance Explores Tapeworm Drug for COVID-19
Reliance Industries Ltd. is working on a new COVID-19 drug and cheaper testing kits as the conglomerate owned by Asia's richest man Mukesh Ambani looks to curb the pathogen which has ravaged India in the past year.
-
Rs 990 Per Sachet For Defence Research Body's Covid Drug '2-DG': Report
The price of a drug for COVID-19 patients developed by India's top defence research body has been fixed at Rs 990 per sachet, news agency ANI reported today quoting unnamed officials.
-
Probe Gautam Gambhir, Others Buying Covid Supplies In Bulk: High Court
The Delhi High court on Monday directed the drug controller to inquire into the issue of politicians buying COVID-19 drugs in bulk amid shortages
